Clinical characteristics of a newly developed ovarian tumour marker, galactosyltransferase associated with tumour (GAT)
- 1 March 1998
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 34 (4) , 489-495
- https://doi.org/10.1016/s0959-8049(97)10079-x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- A New CA125-like Antigen (CA602) Recognized by Two Monoclonal Antibodies against a Newly Established Ovarian Clear Cell Carcinoma Cell Line (RMG-II)Japanese Journal of Cancer Research, 1991
- Serum levels of six tumor markers in patients with benign and malignant gynecological diseaseArchiv für Gynäkologie, 1988
- Abnormal Isoelectric Focusing Patterns of Serum Galactosyltransferase Activity in Patients with Liver NeoplasiaExperimental Biology and Medicine, 1984
- The meaning and use of the area under a receiver operating characteristic (ROC) curve.Radiology, 1982
- Determination of serum galactosyltransferase levels in ovarian cancer patients for the evaluation of the effectiveness of therapeutic programsCancer Letters, 1980
- A Cancer-Associated Galactosyltransferase IsoenzymeNew England Journal of Medicine, 1978
- Glycosyltransferase Levels in Tumors Metastatic to Liver and in Uninvolved Liver Tissue 2JNCI Journal of the National Cancer Institute, 1977
- Cancer-associated isoenzyme of serum galactosyltransferase.Proceedings of the National Academy of Sciences, 1976
- Galactosyltransferase activities in human sera: Detection of a cancer-associated isoenzymeBiochemical and Biophysical Research Communications, 1975
- Glycosyltransferases in human bloodJournal of Clinical Investigation, 1972